Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells

BMC Microbiology (Impact Factor: 2.73). 07/2014; 14(1):177. DOI: 10.1186/1471-2180-14-177
Source: PubMed


Clostridium difficile is the main cause of hospital-acquired diarrhea and colitis known as C. difficile-associated disease (CDAD).With increased severity and failure of treatment in CDAD, new approaches for prevention and treatment, such as the use of probiotics, are needed. Since the pathogenesis of CDAD involves an inflammatory response with a massive influx of neutrophils recruited by interleukin (IL)-8, this study aimed to investigate the probiotic effects of Lactobacillus spp. on the suppression of IL-8 production in response to C. difficile infection.

We screened Lactobacillus conditioned media from 34 infant fecal isolates for the ability to suppress C. difficile-induced IL-8 production from HT-29 cells. Factors produced by two vancomycin-resistant lactobacilli, L. rhamnosus L34 (LR-L34) and L.casei L39 (LC-L39), suppressed the secretion and transcription of IL-8 without inhibiting C. difficile viability or toxin production. Conditioned media from LR-L34 suppressed the activation of phospho-NF-κB with no effect on phospho-c-Jun. However, LC-L39 conditioned media suppressed the activation of both phospho-NF-κB and phospho-c-Jun. Conditioned media from LR-L34 and LC-L39 also decreased the production of C. difficile-induced GM-CSF in HT-29 cells. Immunomodulatory factors present in the conditioned media of both LR-L34 and LC-L39 are heat-stable up to 100°C and > 100 kDa in size.

Our results suggest that L. rhamnosus L34 and L. casei L39 each produce factors capable of modulating inflammation stimulated by C. difficile. These vancomycin-resistant Lactobacillus strains are potential probiotics for treating or preventing CDAD.

Download full-text


Available from: Jennifer Spinler, Jul 18, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to evaluate the capacity of Lactobacillus rhamnosus and/or its products to induce the synthesis of cytokines (TNF- α , IL-1 β , IL-4, IL-6, IL-10, and IL-12) by mouse macrophages (RAW 264.7). Three microorganism preparations were used: live L . rhamnosus (LLR) suspension, heat-killed L . rhamnosus (HKLR) suspension, and the supernatant of a heat-killed L . rhamnosus (SHKLR) suspension, which were cultured with macrophages (37°C, 5% CO 2 ) for 2 h and 30 min. After that, cells were cultured for 16 h. The supernatants were used for the quantitation of cytokines, by ELISA. The results were compared with the synthesis induced by lipopolysaccharide (LPS) and analysed, using ANOVA and Tukey test, 5%. LLR and HKLR groups were able to significantly increase the production of TNF- α , IL-6, and IL-10 ( P < 0 . 05 ). SHKLR also significantly increased the production of TNF- α and IL-10 ( P < 0 . 05 ) but not IL-6 ( P > 0 . 05 ). All the L . rhamnosus suspensions were not able to produce detectable levels of IL-1 β or significant levels of IL-4 and IL-12 ( P > 0 . 05 ). In conclusion, live and heat-killed L . rhamnosus suspensions were able to induce the synthesis of different cytokines with proinflammatory (TNF- α and IL-6) or regulatory (IL-10) functions, suggesting the role of strain L . rhamnosus ATCC 7469 in the modulation or in the stimulation of immune responses.
    01/2015; 2015(2, supplement):1-6. DOI:10.1155/2015/716749
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The intestinal immune system is constantly exposed to foreign antigens, which for the most part should be tolerated. Certain probiotics, prebiotics, and synbiotics are able to influence immune responses. In this review, we highlight the recent publications (within the last 2 years) that have substantially progressed this field. The immunological mechanisms underpinning probiotics, prebiotics, and synbiotics effects continue to be better defined with novel mechanisms being described for dendritic cells, epithelial cells, T regulatory cells, effector lymphocytes, natural killer T cells, and B cells. Many of the mechanisms being described are bacterial strain or metabolite specific, and should not be extrapolated to other probiotics or prebiotics. In addition, the timing of intervention seems to be important, with potentially the greatest effects being observed early in life. In this review, we discuss the recent findings relating to probiotics, prebiotics, and synbiotics, specifically their effects on immunological functions.
    Current Opinion in Gastroenterology 01/2015; 31(2). DOI:10.1097/MOG.0000000000000151 · 4.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to antibiotics is the major risk factor for Clostridium difficile diarrhea (CDD), suggesting that impairment of colonization resistance due to depletion of the gut flora is a significant underlying disease susceptibility factor. Many properties of probiotic organisms indicate that they may be able to replenish the depleted gut flora and restore colonization resistance. However, despite numerous clinical trials, the evidence base for probiotics in the prevention of CDD remains weak. A recent large trial of a multistrain, high-dose probiotic did not show clear evidence of efficacy. The role of probiotics in the prevention of CDD remains unclear. Copyright © 2015 Elsevier Inc. All rights reserved.
    Infectious Disease Clinics of North America 03/2015; 29(1):135-144. DOI:10.1016/j.idc.2014.11.002 · 2.73 Impact Factor
Show more